Autolus Therapeutics PLC
NASDAQ:AUTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
UK |
|
Hydrix Ltd
ASX:HYD
|
AU |
|
R
|
Ryanair Holdings PLC
DUS:RY4C
|
IE |
|
United Overseas Australia Ltd
ASX:UOS
|
MY |
|
I
|
Intersport Polska SA
WSE:IPO
|
PL |
|
Ezra Holdings Ltd
SGX:5DN
|
SG |
|
P
|
Pan Asia Footwear PCL
SET:PAF
|
TH |
|
E
|
EQV Ventures Acquisition Corp
NYSE:EQV
|
US |
|
Braveheart Resources Inc
XTSX:BHT
|
CA |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
Intrinsic Value
The intrinsic value for
Autolus Therapeutics PLC (AUTL) under the Base Case is hidden
USD.
Compared with the current market price of 2.13 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
AUTL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether AUTL usually does or if today's premium is unusual.
See where today’s valuation sits in AUTL’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Autolus Therapeutics PLC.
The intrinsic value for
Autolus Therapeutics PLC (AUTL) under the Base Case is hidden USD.
Compared with the current market price of 2.13 USD, the stock appears hidden.